Nimesulide
Who holds supplier records for Nimesulide? 4 organisations hold a current record for Nimesulide: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Italy (1) and Switzerland (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nimesulide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nimesulide
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nimesulide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AARTI DRUGS LTDIndiaCEP Company GMP cert on recordInactive DMF 20813 · latest filing Aug 2007
- ItalyCEP Company GMP cert on record
- SwitzerlandCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Nimesulide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MANGALAM DRUGS & ORGANICS LTD. Mumbai | IN | R1-CEP 2011-310 - Rev 01 Nimesulide | Mar 2023 | — |
| HAS HEALTHCARE ADVANCED SYNTHESIS SA Biasca | CH | R1-CEP 2010-377 - Rev 02 Nimesulide, Micronised | Mar 2022 | — |
| AARTI DRUGS LIMITED Mumbai | IN | R1-CEP 2002-046 - Rev 06 Nimesulide | May 2019 | — |
| FLAMMA S.P.A. Chignolo d'Isola | IT | R1-CEP 2004-117 - Rev 01 Nimesulide | Nov 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Nimesulide are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- VITAL HEALTH CARE PVT LTDInactive DMF 25302 · filed Aug 2011
- Italy · Inactive DMF 15566 · filed Jul 2001
Overview
Nimesulide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL56367).
Chemical identity
- IUPAC name
- N-(4-nitro-2-phenoxyphenyl)methanesulfonamide
- Canonical SMILES
- CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
- InChIKey
- HYWYRSMBCFDLJT-UHFFFAOYSA-N
- Synonyms
- Aulin, Nimesulida, Nimesulide, NSC-758412, R 805, R-805, Nimesulidum, 4'-Nitro-2'-phenoxymethanesulfonanilide, CHEBI:44445, RefChem:6063, M01AX17, Mesulid
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nimesulide?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Nimesulide: AARTI DRUGS LTD (India), FLAMMA SPA (Italy), HAS Healthcare Advanced Synthesis SA (Switzerland) and Mangalam Drugs & Organics Ltd (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
What do the historical Nimesulide records mean?
2 organisations have only inactive Type II DMFs for Nimesulide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Nimesulide have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Nimesulide on the EDQM register, including MANGALAM DRUGS & ORGANICS LTD. Mumbai (IN), HAS HEALTHCARE ADVANCED SYNTHESIS SA Biasca (CH), AARTI DRUGS LIMITED Mumbai (IN) and FLAMMA S.P.A. Chignolo d'Isola (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Nimesulide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nimesulide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.